Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents by K. M. Lewis et al.
Original Article
Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents  2131 3
Summary
Background Oxidized cellulose is a well known and 
widely used surgical hemostat. It is available in many 
forms, but manufactured using either a nonregenerated 
or regenerated process.
Objective This study compares the fiber structure, pH 
in solution, bactericidal effectiveness, and hemostatic 
effectiveness of an oxidized nonregenerated cellulose 
(ONRC; Traumastem) and an oxidized regenerated cel-
lulose (ORC; Surgicel Original).
Methods In vitro, fiber structures were compared us-
ing scanning electron microscopy, pH of phosphate buf-
fer solution (PBS) and human plasma were measured 
after each cellulose was submerged, and bactericidal 
effect was measured by plating each cellulose with four 
bacteria. In vivo, time to hemostasis and hemostatic 
success were compared using a general surgery nonhep-
arinized porcine liver abrasion model and a peripheral 
vascular surgery heparinized leporine femoral vessel 
bleeding model.
Results Ultrastructure of ONRC fiber is frayed, while 
ORC is smooth. ORC pH is statistically more acidic than 
ONRC in PBS, but equal in plasma. No difference in bac-
tericidal effectiveness was observed. In vivo, ONRC pro-
vided superior time to hemostasis relative to ORC (211.2 
vs 384.6  s, N = 60/group) in the general surgery model; 
and superior hemostatic success relative to ORC at 30 
(60 vs. 15 %; OR: 13.5; 95 % CI: 3.72–49.1, N = 40/group), 
60 (85 vs. 37.5 %; OR: 12.3; 95 % CI: 3.66–41.6), and 90 s 
(97.5 vs 70.0 %; OR: 21.1, 95 % CI: 2.28–195.9) in the pe-
ripheral vascular model.
Conclusion ONRC provides superior hemostasis and 
equivalent bactericidal effectiveness relative to ORC, 
which is likely due to its fiber structure than acidity.
Keywords Traumastem · Surgicel · Cellulose · Oxidized 
cellulose · Hemostasis · Liver abrasion · Liver square · 
Celstat · Fibrin pad
Introduction
Intraoperative bleeding prolongs surgical procedures 
and, if untreated, can lead to secondary complications. 
A number of adjunctive hemostatic agents can be used 
to achieve hemostasis [1], of which topical thrombin, 
porcine collagen, and oxidized cellulose were originally 
used. Oxidized cellulose was first used in 1945 [2], and 
since then it is widely used in all surgical specialties and 
available in many different forms. Oxidized cellulose 
is well known and accepted because of its ease of use, 
favorable biocompatibility, and bactericidal properties.
Oxidized cellulose is a sterile, ready-to-use hemostatic 
gauze. Cellulose is a homopolysaccharide of glucopyra-
nose polymerized through β-glucosidic bonds [3]. Cellu-
lose can be either regenerated to form organized fibers 
or remain nonregenerated with unorganized fibers prior 
to oxidation. When cellulose fibers are treated with dini-
trogen tetroxide, hydoxyl groups are oxidized into car-
boxylic acid groups yielding a polyuronic acid [4]. While 
polyuronic acid is the main component of oxidized cel-
lulose, nonoxidized hydroxyl groups remain as a fibrous 
component.
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The two components of oxidized cellulose undergo 
disparate in vivo degradation processes. The polyuronic 
acid is depolymerized by β-elimination facilitated by gly-
cosidases within 18 h after implantation, and the fibrous 
component is phagocytized and then hydrolyzed by local 
macrophage [3, 5, 6]. The oxidization process makes cel-
lulose susceptible to glycosidases, but also gives oxidized 
cellulose its hemostatic and bactericidal properties.
The low pH of the carboxylic acid groups generates a 
primary local hemostyptic action and secondary plate-
let activation to form a temporary platelet plug [4]. The 
low pH of carboxylic acid groups also generates condi-
tions under which most bacteria cannot survive [7]. The 
bactericidal properties increase as greater concentra-
tions of dinitrogen tetroxide are used to oxidize cellu-
lose [8]. The bactericidal properties of oxidized cellulose 
are also dependent on the knit structure and thickness, 
where thinner loose-knit patterns are less effective than 
thicker tight-knit patterns against antibiotic-resistant 
microorganisms [9]. Since both the hemostatic and bac-
tericidal effects are affiliated with the low pH generated 
by carboxylic acid, our hypothesis is that the hemostatic 
properties—like the bactericidal properties—of oxidized 
cellulose are also affected by the fiber structure and 
thickness.
Therefore, the objective of this study is to compare 
the fiber, pH in solution, bactericidal effectiveness, and 
hemostatic effectiveness of an oxidized nonregenerated 
cellulose (Traumastem, Bioster a.s., Czech Republic) 
and an oxidized regenerated cellulose (Surgicel Origi-
nal, Ethicon, Inc., New Jersey, USA). The hypothesis of 
the study is that the oxidized nonregenerated cellulose 
(Traumastem) will have a greater surface area as seen 
on scanning electron microscopy, an equivalent pH 
in solution, a greater bactericidal effectiveness, and a 
greater in vivo effectiveness based on a nonheparinized 
porcine hepatic abrasion model and a heparinized lepo-
rine femoral vein model.
Materials and methods
Oxidized cellulose agents
Traumastem is nonregenerated oxidized cellulose, 
which is also known as Celstat in North America. Surgicel 
Original is regenerated oxidized cellulose, which is also 
known as Tabotamp in Europe.
In vitro comparisons
Ultrastructure Scanning electron microscopy (SEM) 
was used to compare the ultrastructure of the oxidized 
cellulose products. A strip of each material was cut and 
mounted onto aluminum stubs with carbon tape. Sam-
ples were then photographed and coated with palladium 
gold with a sputter coater (EMITECH SC7620, Quorum 
Technologies, Ltd., West Sussex, UK). The coated mate-
rial was examined using a Jeol JSM-6510 Scanning Elec-
tron Microscope (Jeol USA, Inc., Peabody, Massachu-
setts, USA) and representative images were taken from 
both materials in the same magnification.
pH in solution The pH of phosphate buffer solution 
(PBS; Invitrogen, Grand Island, New York, USA) and 
pooled human plasma (Baxter AG, Vienna, Austria) was 
measured 12, 30, and 60 min after a 2 × 2 cm piece of oxi-
dized cellulose was submerged in solution. An additional 
90 min time point was added for plasma. A total of nine 
pH measurements were taken at each time point.
Bactericidal activity Pieces of oxidized cellulose and 
sterile gauze were cut to weigh 150 ± 2 mg and individu-
ally placed into a sterile Falcon test tube (BD, Franklin 
Lakes, New Jersey, USA). A 166  μL sample of Staphylo-
coccus aureus (ATCC 6538, 4.7 × 107 CFU), Streptococcus 
pyogenes (ATCC 19615, 4.5 × 107), Pseudomonas aerugi-
nosa (ATCC 9027, 6.1 × 107 CFU), or Enterococcus faecium 
(ATCC 6057, 5.7 × 107 CFU) and 3  ml of TSB-Bouillon 
broth were added to each tube and maintained at 37 °C. 
Two samples from each tube were taken at 0, 1, 6, and 
24 h after being added to the tube. The samples were then 
plated for 24 h at 37 °C after which Colony Forming Units 
(CFUs) were counted.
In vivo comparisons
Two in vivo models were used to compare the hemo-
static effectiveness of the oxidized cellulose products, 
one mimicking general surgery and the other peripheral 
vascular surgery. The nonheparinized porcine hepatic 
square model was used to compare time to hemostasis 
and hemostatic success 10 min after application [10]. A 
heparinized leporine femoral vein bleeding model was 
used to compare hemostatic success at 30, 60, and 90 s 
after application. All animal activities were performed 
according to the United States Animal Welfare Act and 
The Guide for the Care and Use of Laboratory Animals in 
an AAALAC accredited institution.
The nonheparinized porcine hepatic square model 
was performed by incising a pair of 1 × 1 cm squares into 
the hepatic capsule, then avulsing the capsule 2–3  mm 
deep to create a diffuse mixed bleed of venous, venule, 
and arteriole strength. The square lesions were then 
treated with a single ply of oxidized cellulose cut to 
2 × 2  cm squares. The oxidized cellulose products were 
applied in pairs randomized to one of the two paired 
lesions. A total of 60 lesions per group were performed 
across five female pigs weighing 30–35 kg. A single sur-
geon, who created and treated the lesions, was blinded to 
treatment and the randomization scheme. The surgeon 
blotted both lesions, then applied the hemostats with 
30 s of even digital pressure, after which they remained 
untouched and observed for 10 min. The time to hemo-
stasis was recorded in seconds and hemostatic success 
was determined at 10 min. The minimum time to hemo-
stasis that could be recorded was 30 s and the maximum 
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was 600 s. Hemostatic success was defined as no bleeding 
or minimal ooze. Representative lesions treated with oxi-
dized cellulose were collected for immunohistochemisty 
and stained brown using a primary mouse monoclonal 
antibody against human fibrinogen and fibrin (Ameri-
can Diagnostica Inc., Stamford, CT, USA) and a primary 
mouse monoclonal antibody against human Selectin P 
antigen (also known as CD62P) on platelets (Lifespan 
BioSciences, Seattle, WA, USA). Each primary antibody 
was labeled with a secondary antibody, Mouse-on-Farma 
HRP-Polymer (BioCare Medical, Concord, CA, USA).
The heparinized leporine femoral vein model was 
performed by exposing the femoral veins bilaterally and 
passing a 5 mm length of 5-0 polyglactin 910 on an RB-1 
taper needle in a proximal-to-distal direction through 
each vein. The proximal and distal bleeds of each vein 
were then treated with a single ply of oxidized cellulose cut 
to 1 × 1 cm. The oxidized cellulose products were applied 
in pairs randomized to one of the two paired lesions. A 
total of 40 lesions per group were performed across 20 
female New Zealand white rabbits weighing 3.0–3.5  kg. 
Two surgeons created and treated the lesions. The hemo-
stats were applied as described above and observed for 
90 s. An initial bleed rate was measured from each lesion 
prior to treatment using preweighed gauze for 10 s. The 
bleed rate of “g/10 s” was converted to “ml/min” using 
1 g equaling 1 ml [11]. Hemostatic success was defined 
as no bleeding and assessed at 30, 60, and 90 s after treat-
ment. The more strict definition of hemostatic success 
and the use of heparin served to reflect the cardiovascu-
lar surgical condition and increase the sensitivity of the 
animal model. Once hemostasis was achieved a second 
series of identical lesions were performed distal of the 
first series. All rabbits were heparinized (300 IU/kg, I.V.) 
approximately 30 min prior to the first lesion series.
Statistical analysis
In vitro pH comparison
The pH difference between nonregenerated and regener-
ated oxidized cellulose groups submerged in PBS at 12, 
30, 60 min and plasma at 12, 30, 60 and 90 min were esti-
mated (SAS procedure MIXED). The mean difference and 
its 95 % confidence interval were computed and statisti-
cal significance defined as p < 0.05.
Nonheparinized porcine hepatic square model This 
general surgery model was designed to detect the 
geometric mean ratio of “regenerated/nonregenerated” 
equaling 1.25 based on log time to hemostasis. The 
standard deviation of log time to hemostasis was 
conservatively assumed to be 0.35, where 53 lesions per 
group were required with a two-sided α of 0.05 and power 
of 0.9. A total of five animals were used to create a total of 
120 lesions (N = 60 lesions per group) to assure statistically 
meaningful results. The analysis of covariance (SAS pro-
cedure MIXED) on log transformed seconds to hemosta-
sis data was performed. Independent variables included 
the treatment groups. Covariates included pig, liver lobe 
(left lateral, medial, or right lateral), and baseline bleeding 
rate (pretreatment). The geometric mean ratio of “regen-
erated/nonregenerated” and its 95 % confidence interval 
were computed. If any of the covariate effects, except the 
baseline bleeding score, were not significant (p > 0.05), 
the analysis was based on the reduced model of those 
covariates that were statistically significant (p < 0.05).
Heparinized leporine femoral vein bleeding model This 
peripheral vascular model was designed to detect a differ-
ence in rates of 80 % versus 40 % with α = 0.05 and power 
= 90 % based on a standard test of equal proportions per 
time point. Forty lesions per group were required with a 
two-sided α of 0.05 and power of 0.9. A total of 20 rab-
bits, each having four lesions each, were used to create a 
total of 80 lesions (N = 40 per group). A logistic regression 
model (SAS procedure GENMOD) was performed based 
on the success odds ratios of each treatment. Indepen-
dent variables included the treatment groups. Covariates 
included the hind limb (right or left), location (proximal 
or distal), and initial bleeding. If any of the covariate 
effects, except the baseline bleeding score, were not sig-
nificant (p > 0.05), the analysis was based on the reduced 




The gross appearance of the oxidized cellulose products 
did not remarkably differ; however, the ultrastructural 
appearance did (Fig. 1). Nonregenerated oxidized cellu-
lose had frayed fibers, while regenerated oxidized cellu-
lose had condensed fibers. The knit tightness was visually 
equal.
The pH of PBS with nonregenerated oxidized cellulose 
relative to regenerated oxidized cellulose was signifi-
cantly higher at all time points (Table 1). Whereas, the pH 
of human pooled plasma with nonregenerated oxidized 
cellulose was not statistically different at all time points 
but 12  min relative to regenerated oxidized cellulose 
(Table 1).
The bactericidal effect of the oxidized cellulose prod-
ucts was identical except against E. faecium at 1 h (Fig. 2). 
The bactericidal effects, however, did not differ after 6 h 
against E. faecium. As expected, the negative control 
gauze had no bactericidal effect over time.
In vivo comparisons
Nonregenerated cellulose (Traumastem) provided 
superior shorter median time to hemostasis than regener-
ated cellulose (Surgicel Original) in the nonheparinized 
porcine hepatic square model (211.2 vs 384.6 s, N = 60 per 
216  Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents
Original Article
1 3
group; Fig. 3). The statistical significance is based on the 
geometric mean ratio of “regenerated/nonregenerated” 
equaling 1.857 (95 % CI: 1.669–2.065), which is far greater 
than 1.0 representing superiority of nonregenerated cel-
lulose. The hemostatic success at 10 min after application 
was greater in the nonregenerated cellulose treatment 
group relative to the regenerated cellulose treatment 
group (100 vs 96.6 %, N = 60 per group). The amount of 
bleeding was consistently visually greater from the regen-
erated cellulose treated lesions than the nonregenerated 
cellulose treated lesions (Fig.  4). The excess blood loss 
of the regenerated cellulose treated lesions is observed 
by the increased fibrin formation and platelet activation 
histologically (Fig.  5). Both oxidized celluloses have a 
characteristic ghost appearance histologically because 
each is dissolved during histological processing [12].
Similarly, nonregenerated cellulose (Traumastem) 
provided superior hemostasis in the heparinized lepo-
rine femoral bleeding model relative to regenerated 
cellulose (Surgicel Original; Fig.  6). The success of 
nonregenerated cellulose was superior to regenerated 
cellulose based on Odds Ratio of Success (OR, “nonre-
generated/regenerated”) at 30  s (60 vs. 15 %; OR: 13.5; 
95 % CI: 3.72–49.1, N = 40 per group), 60 s (85 vs. 37.5 %; 
OR: 12.3; 95 % CI: 3.66–41.6), and 90 s (97.5 vs 70.0 %; OR: 
21.1, 95 % CI: 2.28–195.9). These 95 % confidence limits of 
OR at 30, 60, and 90 s are far greater than 1.0 represent-
ing superiority of nonregenerated cellulose. The initial 
bleeding prior to treatment was similar in both groups 
(3.44 ± 1.8 vs 3.60 ± 1.8 ml/min, N = 40 per group).
Discussion
To our knowledge, this is the first study to compare the in 
vitro and in vivo properties of nonregenerated and regen-
Table 1 Mean pH of solution at various time points after submersion of Traumastem, a nonregenerated oxidized cellulose, 
and Surgicel Original, a regenerated oxidized cellulose
Solution Time point 
(minutes)
Mean pH of solutiona Mean difference 95 % confidence limit P value
Traumastem Surgicel Lower Upper
PBS 12 1.92 ± 0.05 1.82 ± 0.03 0.10 0.08 0.12 < 0.0001
30 1.92 ± 0.05 1.81 ± 0.03 0.11 0.09 0.13 < 0.0001
60 1.91 ± 0.05 1.80 ± 0.02 0.10 0.08 0.12 < 0.0001
Plasma 12 3.72 ± 0.22 3.48 ± 0.10 0.24 0.14 0.33 0.0002
30 3.50 ± 0.17 3.41 ± 0.09 0.09 − 0.00 0.18 0.0611
60 3.39 ± 0.15 3.37 ± 0.08 0.02 − 0.07 0.11 0.6058
90 3.35 ± 0.13 3.37 ± 0.06 − 0.02 − 0.08 0.05 0.5694
aN = 9 per product per time point, mean ± standard deviation
            
Fig. 1 Gross and ultra-
structural appearance of 
Traumastem, a nonregener-
ated oxidized cellulose  
(a, c), and Surgicel Original, 
a regenerated oxidized cel-
lulose (b, d)
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erated oxidized cellulose. The in vitro comparisons dem-
onstrated different fiber structures, different pH while in 
PBS, and similar pH while in human plasma, but did not 
detect a bactericidal difference. The in vivo hemostasis 
models demonstrated that nonregenerated oxidized cel-
lulose provided superior hemostasis. It was unexpected 
that bactericidal differences would not be detected while 
hemostatic differences would be detected, because both 
effects are a result of the materials’ pH. Since the pH of 
each is similar in human plasma, the difference in hemo-
static performance is likely a result of the frayed fibers of 
the nonregenerated oxidized cellulose, which are seen in 
the SEM images. The frayed fibers of nonregenerated oxi-
dized cellulose create a greater surface area than that of 
the regenerated oxidized cellulose.
Fig. 2 Bactericidal effect of Traumastem, non-regenerated oxidized cellulose, and Surgicel Original, regenerated oxidized 
cellulose, against a Staphylococcus aureus (ATCC 6538), b Pseudomonas aeruginosa (ATCC 9027), c Streptococcus pyogenes 
(ATCC 19615), and d Enterococcus faecium (ATCC 6057) relative to a sterile gauze negative control. Time point 0 represents 
baseline colony forming units (CFUs) prior to treatment
            
            
Fig. 3 Box plot of the time to hemostasis in a nonheparin-
ized porcine hepatic square model (N = 60 lesions per group). 
Traumastem, a nonregenerated oxidized cellulose, provides 
superior hemostasis relative to Surgicel Original, a regenerat-
ed oxidized cellulose (* statistical significance based on geo-
metrical mean ratio of 1.857 [95 % CI: 1.669–2.065]). Range, 
25th, 50th, and 75th percentiles are depicted
Fig. 4 Representative hepatic square lesions on the lateral 
aspect of the left lateral lobe treated with Traumastem, a 
nonregenerated cellulose (left), and Surgicel Original, a re-
generated cellulose (right); where excess blood loss is ob-
served from the regenerated cellulose treated lesion, while 
hemostasis is provided by nonregenerated cellulose
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The in vivo hemostatic performance of nonregenerated 
oxidized cellulose was superior of regenerated oxidized cel-
lulose in both the non-heparinized porcine hepatic square 
model and heparinized leporine femoral vein bleeding 
model. The greatest performance differences were seen in 
time to hemostasis rather than 10 min after application in 
the general surgery model, where median time to hemo-
stasis of nonregenerated oxidized cellulose was half of 
regenerated oxidized cellulose. Similarly, in the peripheral 
vascular model, nonregenerated oxidized cellulose had two 
times greater hemostatic success than regenerated oxidized 
cellulose 30 and 60 s after application. Though regenerated 
cellulose improved at 90  s after application, nonregener-
ated oxidized cellulose was still superior to regenerated 
oxidized cellulose with a difference of 17.5 %. While clini-
cal data comparing these two agents are not available, the 
superior performance of nonregenerated cellulose in these 
models is expected to be clinically meaningful.
The preclinical models were designed to have high clini-
cal predictability to the clinical setting. The general surgery 
model was selected because of the high acceptance and use 
of swine as a hemostatic model [10, 13]. The vascular sur-
gery model was designed such that coagulation differences 
between rabbits and humans were minimized by heparin-
ization. Heparin, 300 IU/kg, was administered 30 min prior 
to creating the vascular lesions to target an activated clotting 
time 1.8–2.0x baseline as is required in humans for periph-
eral vascular surgery [14]. Therefore, the preclinical models 
are expected to be clinically predictive for effectiveness. In 
regard to safety, no intraoperative side effects or signs of 
toxicity were observed during these studies. The resorption 
time of regenerated oxidized cellulose depends on several 
factors and is not fully known, as reported by the manu-
facturer; while, the resorption time of nonregenerated oxi-
dized cellulose is known to be 8 days in animal studies.
The ability to improve the hemostatic performance of 
either nonregenerated or regenerated oxidized cellulose 
is limited without neutralizing the carboxylic acid groups. 
The low pH of oxidized cellulose immediately dena-
tures plasma proteins (e.g., thrombin, fibrinogen, tissue 
factor, etc.). Co-administration of oxidized cellulose and 
thrombin, fibrinogen, or alike, renders these plasma pro-
teins ineffective. The low pH of oxidized cellulose is nec-
essary for its hemostyptic and bactericidal properties. 
Fig. 6 Hemostatic success 30, 60, and 90 s after treatment for 
Traumastem, a nonregenerated cellulose, and Surgicel Orig-
inal, a regenerated cellulose, in a heparinized leporine femo-
ral bleeding model (N = 40 lesions per group). Traumastem is 
superior to Surgicel at all time points based on an odds ratio 
of success (* 13.5 [95 % CI: 3.72–49.1]; ** 12.3 [3.66–41.6]; 
*** 21.1 [2.28–195.9])
            
Fig. 5 Representative hepat-
ic square lesions treated with 
Traumastem, a nonregener-
ated cellulose (left images), 
and Surgicel, a regenerated 
oxidized cellulose (right im-
ages) stained brown with a 
monoclonal antibody against 
fibrin (upper images) and the 
CD62 antigen on platelets 
(lower images). Images are 
10x, insets are 40x. Surgicel 
treated lesions have greater 
fibrin and platelets due to 
excessive bleeding, while 
Traumastem treated lesions 
have less fibrin and plate-
lets due to faster time to 
hemostasis. T  Traumastem, 
S Surgicel, L  Liver, F Fibrin, 
P  Platelets
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Unlike the hemostatic properties, the bactericidal prop-
erties of oxidized cellulose can be enhanced by modifica-
tion with silver and zinc ions [15].
The bactericidal effect of nonregenerated and regener-
ated oxidized cellulose was identical against all bacteria 
tested except E. faecium. The difference between the cel-
luloses was only observed 1  h after plating. The reason 
for the difference is not known, but the difference was 
resolved at 6 h after plating. Spangler et al. reported the 
bactericidal effectiveness of regenerated oxidized cellu-
lose against P. aeruginosa and S. aureus [9]. In their report 
regenerated oxidized cellulose had a similar effective-
ness against P. aeruginosa, but less effectiveness against 
S. aureus relative to our report. The 5 log unit difference 
between the studies of regenerated oxidized cellulose 
against S. aureus was seen 6  h after being plated and 
was resolved by 24  h after being plated. Sprangler used 
165 ± 5 mg of regenerated oxidized cellulose, whereas we 
used 150 ± 2 mg.
Interestingly, the pH of nonregenerated and regener-
ated oxidized cellulose differed in PBS, but not in human 
plasma. The more acidic pH of regenerated oxidized cel-
lulose is revealed in the less buffered solution of PBS. PBS 
is an anorganic buffer, which lacks proteins and organic 
compounds present in plasma. As a result, the pH of PBS 
drops quickly as the solution reaches equilibrium. The 
pH of plasma too equilibrates, but does so slowly as the 
carbonate, organic compounds, and anorganic buffers 
are overcome. The greater acidity of regenerated oxidized 
cellulose has the potential of inducing greater and unde-
sirable tissue damage in nonbuffered clinical conditions 
(e.g., acidosis secondary to blood loss or inadequate 
tissue perfusion). Though the acidity of regenerated 
oxidized cellulose is greater than nonregenerated oxi-
dized cellulose, no differences in bactericidal effect were 
observed. This may suggest that a threshold pH exists, 
where under no further bactericidal effect is observed.
This study is the first to find that nonregenerated oxi-
dized cellulose has a greater surface area, equivalent 
bactericidal effect, and superior hemostatic properties in 
vivo under nonheparinized and heparinized conditions 
relative to regenerated oxidized cellulose. These findings, 
further, support the hypothesis that fiber structure and 
thickness effect hemostatic properties of oxidized cellu-
lose based hemostatic agents. While oxidized cellulose is 
used in nearly all surgical specialties for its ease of use, 
biocompatibility and bactericidal properties, the non-
regenerated oxidized cellulose is likely to become more 
favored after additional clinical studies are performed 
and surgical experiences are gained.
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